Mission Produce falls 5.8% as a company-specific move follows investor-day targets

What happened

Mission Produce (AVO) fell 5.8% to $11.79 on October 8, 2026, a large, mostly company-specific move that followed the company outlining multi-year targets at its 2026 Investor Day. Trading volume was 3.0 times its 20-day average, and the session outstripped both the market and its sector in magnitude. The S&P 500 fell 0.5% on the day while the Consumer Defensive sector median rose 1.7%, making the stock’s decline 7.4 percentage points worse than the sector median.

How big was the move

The session was 2.7 times a typical daily move for this stock, indicating company news was the likely driver. The stock opened 0.1% above the previous close but finished down 5.8% and has fallen 8.0% over the last five sessions. Market sensitivity is muted: the stock’s beta is 0.43, so the stock tends to move less than the market. In the past five years the stock had 13 sessions with a decline of at least 5.8%; twenty trading days later the median result was a gain of 0.2%, and 7 of 13 were higher.

The technical picture

The stock sits below its key moving averages, trading 7.5% below its 20-day moving average, 8.2% below its 50-day moving average and 8.6% below its 200-day moving average. The 50-day average is below the 200-day average, a sign of a weak longer-term trend. The Relative Strength Index (14 days) read 31, within the neutral range between 30 and 70. Over the last month the stock fell 12.1% and over three months it fell 11.6%; over one year the stock rose 1.3%, which is 14.4 percentage points behind the S&P 500. Volatility was 33% annualized over 60 days, a level lower than 51% of its own readings over five years, and the distance from the 52-week high was 24.1%.

Taken together, the technical signals point to recent weakness. The shortfall versus moving averages and the below-median volatility suggest the recent sell-off was concentrated rather than driven by a broad spike in trading stress, consistent with the identification of a large, mostly company-specific move.

Fundamentals and valuation

For the four quarters through July 31, 2026, revenue was $1.34 billion, a decline of 6.2% from a year earlier. Diluted earnings per share were $0.03, and earnings per share growth from a year earlier rose 263.2%. Gross margin was 11.4% compared with 11.3% a year earlier, while operating margin was 3.2% versus 4.6% a year earlier. Free-cash-flow margin stood at 0.2% and return on invested capital was 0.7%. The balance sheet shows net debt of 7.0 times EBITDA and the share count over one year increased by 16.6%.

Valuation metrics are unusually stretched on a trailing basis: the stock trades at 373.1 times trailing earnings, a reading higher than 79% of its own readings over the past five years, where the five-year median was 36.7 times earnings. Price to forward earnings was 18.7 times expected earnings and free-cash-flow yield was 0.2%. Those figures present a wide gap between historical trailing valuation and near-term forward multiples, while heavy leverage on the balance sheet amplifies risk if earnings or cash flow soften.

Earnings and analyst expectations

Mission Produce last reported on September 8, 2026, posting earnings per share of $0.18 against $0.12 expected, 56.5% above estimates. That report marked one consecutive quarter beating estimates and the average surprise over the last four reports was 12.1% above estimates. Typical two-day reactions after recent reports have seen the stock fall 0.3%. The next scheduled report is December 17, 2026.

Six analysts covered the stock and the consensus rating was Buy; 83% of analysts gave it a Buy or equivalent recommendation. The consensus price target was $16.00, which was 35.7% above the closing price on October 8, 2026. Investors weighing the stock face the contrast of near-term analyst optimism with a very high trailing price-to-earnings multiple and substantial leverage on the balance sheet.

What to watch

• December 17, 2026: next scheduled earnings report (measurable date)
• The company’s five-year targets from its 2026 Investor Day: a mid-single-digit range for organic sales growth and margin expansion of 300 basis points (reported by GlobeNewsWire and Seeking Alpha)
• Balance-sheet leverage: net debt of 7.0 times EBITDA (measurable)
• Valuation gap: 373.1 times trailing earnings versus price to forward earnings of 18.7 times expected earnings (measurable)
• Share count trend: increased by 16.6% over one year (measurable)